Kinarus Therapeutics Holding AG: Kinarus Therapeutics Phase 2 KINFAST Covid-19 Clinical Trial Progress Update : vimarsana.com

Kinarus Therapeutics Holding AG / Key word(s): Research Update/Study Kinarus Therapeutics Phase 2 KINFAST Covid-19 Clinical Trial Progress Update 21.02.2023 / 07:00 CET/CEST MEDIA

Related Keywords

Germany , Switzerland , Swiss , Dennis Riedl , Chris Maggos , Thierry Fumeaux , Kinarus Therapeutics Holding Ag Key , Swiss Federal Office Of Public Health , Research Update Study , Cohesion Bureau , Kinarus Therapeutics Holding , Programme For Covid , Therapeutics Phase , Trial Progress Update , Therapeutics Holding , Chief Medical Officer , Kinarus Therapeutics , Swiss Federal Office , Kinarus , Herapeutics , Olding , Hase , Infast , Ovid , Linical , Rial , Rogress , Pdate ,